Site icon Kathmandu Clinic

Kratom

Kratom

I was recently approached by one my patients about using Kratom. There is a documentary from 2018 that has given Kratom more attention recently. If you live in the St. Louis area you may have also noticed some new CBD Kratom stores opening up. In addition to CBD, I didn’t learn about this plant in medical school, so I decided to do some research. The following is what the formal medical community says about Kratom.

Kratom (Mitragyna speciosa), is an South-east Asian traditional herb with opioid and stimulant-like properties, contains indole alkaloids, principally mitragynine and 7-hydroxymitragynine, with mu-opioid receptor agonism. Mu-opioid receptors are the receptors in your brain and body where the endogenous (your body’s naturally occurring opiates like, endorphins) and exogenous opioids (these are medications such as morphine, codeine, hydrocodone and the like) exert their activity.

Kratom has been used for self-treatment of opioid withdrawal, with little evidence based research of efficacy. Additionally, there have been increasing numbers of reports of lethal overdose and other adverse effects. Kratom should not be used in patients actively withdrawing from opioids, however, some people report relief with Kratom when they are not in active opioid withdrawal.

Investigation of Kratom’s efficacy and toxicity is limited to case reports. In higher doses of 5 to 15 g, frequent and prolonged ingestion of Kratom for pain or recreational use has been associated with respiratory depression (decreased drive of breathing), anorexia, weight loss, seizures, depression, psychosis, physiologic tolerance, and withdrawal (similar to that seen with opioid withdrawal). Opioid withdrawal symptoms can emerge 12 to 24 hours after last use of Kratom and persist for up to seven days. There are no controlled trials supportive of specific pharmacologic treatment of Kratom withdrawal, but a 2019 review suggested treatment similar to withdrawal from other opioids, specifically using alpha-2-adrenergic agonists and symptomatic treatment.

Kratom use is prohibited in some countries and US states. The Food and Drug Administration in the United States has issued multiple advisories on Kratom. For example the advisories include, the health risks with its use for opioid withdrawal, its association with a multi-state Salmonella outbreak in 2018, and on a mandatory recall of Kratom-containing products associated with Triangle Pharmanaturals, LLC in 2018.

Here is my take on all of the above about Kratom for use:

Exit mobile version